RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
153 hedge funds and large institutions have $1.25B invested in Revance Therapeutics, Inc. in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 64 increasing their positions, 38 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
35% less call options, than puts
Call options by funds: $6.79M | Put options by funds: $10.5M
Holders
153
Holding in Top 10
2
Calls
$6.79M
Puts
$10.5M
Top Buyers
| 1 | +$11.1M | |
| 2 | +$7.3M | |
| 3 | +$6.49M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$6.12M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$4.38M |
Top Sellers
| 1 | -$22.3M | |
| 2 | -$20.5M | |
| 3 | -$9.63M | |
| 4 |
FI
Fosun International
Hong Kong,
China
|
-$5.28M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.88M |